Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term plus gemcitabine. Found 3 abstracts

Astsaturov IA, Meropol NJ, Alpaugh RK, Burtness BA, Cheng JD, McLaughlin S, Rogatko A, Xu ZH, Watson JC, Weiner LM, Cohen SJ. Phase II and Coagulation Cascade Biomarker Study of Bevacizumab With or Without Docetaxel in Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma. American Journal of Clinical Oncology-Cancer Clinical Trials. 2011 Feb;34(1):70-5.   PMCID: PMC3030655
Langer CJ. Dilemmas in management: The controversial role of chemotherapy in PS 2 advanced NSCLC and the potential role of CT-2103 (Xyotax (TM)). The oncologist. 2004 Jan;9(4):398-405.
Langer CJ. The Lilenbaum article reviewed. ONCOLOGY-NEW YORK. 2004 Sep;18(10):1330-3.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term plus gemcitabine

Last updated on Wednesday, February 05, 2020